Lung Ultrasound in Pediatric Acute Chest Syndrome

Recruiting Observational Study
Sickle Cell Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 Month – 17
Sex
Any
Study type
Observational
Participants needed
60 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Sickle-cell disease is a common disease with serious complications, in particular acute chest syndrome (ACS), which can be life threatening. The pathophysiology of ACS is poorly understood, but alveolar hypoventilation appears to play an important role. Pulmonary ultrasound is increasingly used in pediatrics to diagnose ACS. The management of ACS is complex, including oxygen therapy, antibiotics, …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Sickle cell disease patient aged 1 month to 17 years * Hospitalisation in the PICU of Robert-Debre hospital * Suspicion of acute chest syndrome ACS * No objection from a legal representative or the child taken in by the doctor. Exclusion Criteria: * Refusal of parents * Dela…
Contacts

Aurélie HAYOTTE, MD

+33.1.40.03.36.49

aurelie.hayotte@aphp.fr

CONTACT

Michaël LEVY, MD, PhD

0140034098

michael.levy@aphp.fr

CONTACT